Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Extraordinary shareholders’ meeting of Mentice AB

The shareholders in Mentice AB, reg. no. 556556-4241, are hereby invited to attend the extraordinary shareholders’ meeting to be held on Wednesday 28 August 2019 at 3.00 pm. at the company’s premises at Odinsgatan 10 in Gothenburg. Registration takes place from 2.00 pm.   Right to participate and notice Only shareholders who are recorded in their own name in the company’s share ledger kept by Euroclear Sweden AB (The Swedish Central Securities Depository Euroclear Sweden AB) as of Thursday 22 August 2019 have the right to participate in the shareholders’ meeting. Shareholders

Half-year Report Quartiers Properties – January to June 2019

Quartiers Properties AB (publ) (“Quartiers Properties” or “the company”) has today published the company’s half-year report for the January to June 2019 period.Summary of the period  · Net sales totalled SEK 56,389 thousand (SEK 3,242 thousand). The significant increase in net sales in the first half of the year was mainly due to sales of completed projects, which totalled SEK 49,234 thousand (0) during the period. In addition, revenues from the rental business also increased compared with the previous year. · Operating profit excluding changes in value was SEK 212 thousand,

Interim report 2018-09-01 - 2019-05-31

Third quarter report By "NextCell", “NXTCL” or "Company" is meant NextCell Pharma AB with organization number 556965-8361. “Spotlight" refers to the Spotlight Stock Market (previous AktieTorget). Amount in brackets refer to the corresponding period in the previous year. Note that the Company's fiscal year is September 1 - August 31. This English version is a translation of the Swedish version. The Swedish version is at all time to be seen as the leading document. Nine months (2018-09-01 until 2019-05-31) · Operating income amounted to SEK 1 410 055 (527 545). · Operating result

Change in the number of shares and votes in Q-linea AB

Q-linea AB (publ) (”Q-linea” or ”the Company”), today announced that the number of shares and votes in Q-linea has increased during the month of July due to the new share issue carried out to ensure delivery of performance shares within the framework of the long-term incentive programme that was resolved by the annual general meeting on 22 May 2019. A total of 117,424 shares and votes have been added. At 31 July 2019, which is the last trading day in July, the number of shares and votes in the Company amounts to 23,235,387. All shares are ordinary shares.   For further information,

Change in number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, July 31st, 2019, Moberg Pharma AB (OMX: MOB). The number of shares and votes in Moberg Pharma AB (publ) (“Moberg Pharma”) has increased by 488,905 ordinary shares in July 2019. Therefore, there are in total 18,853,510 shares and votes in the company as of July 31st 2019, of which 18,192,667 are ordinary shares and 660,843 are shares of series B.The total number of shares and votes has increased as a result of 488,905 ordinary shares issued after exercise of warrants under Moberg Pharma’s share-based incentive program. Due to the exercise of the warrants, the total number of

CONVENING NOTICE FOR EXTRAORDINARY GENERAL MEETING IN RANPLAN GROUP AB

Ranplan Group AB (publ) publishes convening notice for extraordinary general meeting and proposes – on the basis of shareholders representing more than 70% of the outstanding votes – Tomas Isaksson, as a new ordinary member of the board, and the election of Prof. Jie Zhang, as new Chairman of the board, all effective after close of the EGM. In conjunction, Lars-Inge Sjöqvist, ordinary member of the board, and Mats Andersson, Chairman of the board, will step down subject to its approval at the EGM. Due to time constraints, Alastair Williamson, current CEO of Ranplan who will join Wyld Networks

Photocure ASA: Invitation to second quarter and first half year 2019 results presentation and webcast

Photocure will present its second quarter and first half year report on Wednesday 7 August 2019 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET).Representatives from the company will be Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English. The quarterly report and presentation will be published at 07:00 CET and will be publicly available at www.photocure.com. It will be possible to follow the presentation through https://webtv.hegnar.no/presentation.php?webcastId=98041425  A light snack will be served from 08:00 (CET). The

Nomination committee propose new board members in Mentice AB prior to convening an Extraordinary Shareholders’ Meeting on August 28, 2019

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee proposes that the board be extended with three members to a total of seven members. The nomination committee intends to suggest the election of Denis Gestin, Gösta Johannesson and David Ballard. The nomination committee proposes that the extraordinary shareholders’ meeting resolves to approve and appoint three new board members to the board of directors. The board of directors propose that the following

Notice of Extraordinary General Meeting in Gunnebo AB (publ)

The shareholders of Gunnebo AB (publ), corporate ID No. 556438-2629, are hereby invited to attend the extraordinary general meeting (the ”EGM”) to be held on Monday, 26 August 2019 at 10.00 a.m. CEST, at Västsvenska Handelskammaren, Parkgatan 49 in Gothenburg, Sweden. Registration of attendance commences at 09.30 a.m. CEST.Right to attend A shareholder who wish to attend the EGM must: ·  be recorded in the share register for the company maintained by Euroclear Sweden AB, as of Tuesday, 20 August 2019, and ·  notify the company of its intention to attend the EGM by Tuesday, 20

Increased number of shares and votes in Hemfosa

The number of shares and votes in Hemfosa Fastigheter AB has increased as a result of a new share issue resolved upon by the board on July 3, 2019. The ordinary shares were used as payment in a property acquisition. Through the new share issue the number of ordinary shares and votes in the company increased by 1,760,000 ordinary shares and 1,760,000 votes. At the last trading day of July there were in total 180,488,248 shares in the company (169,488,249 ordinary shares and 10,999,999 preference shares) and 170,588,248.9 votes. For further information, please contact:   Caroline

Number of shares and votes in Calliditas Therapeutics

During July, the number of shares and votes in Calliditas Therapeutics AB (publ) (the “Company”) has increased due to the directed share issue of 3,505,291 new shares that the Company carried out in beginning of July, 2019. As of July 31, 2019, the number of shares and votes in the Company amounts to 38,707,638.For further information, please contact: Renée Aguiar-Lucander, CEO at Calliditas Email: renee.lucander@calliditas.com  Telephone: +46 722 52 10 06 Mikael Widell, Head of Communications at Calliditas Email: mikael.widell@calliditas.com Telephone: +46 703 11 99 60

New number of shares in Handelsbanken

Due to an exchange of convertible notes in Svenska Handelsbanken AB, the number of Class A shares has increased by 3 901 900 shares and the number of votes has increased by 3 901 900.Following the increase, the total number of shares in Handelsbanken is 1 955 017 808  of which 1 919 766 479 are Class A shares and 35 251 329 are Class B shares. The total number of votes in Handelsbanken is 1 923 291 611,9. The share capital amounts to SEK 3 027 277 602,40 after the increase. For further information, please contact:Lars Höglund, Head of Investor Relations: +46 8–701 51 70,+46 70–345

Integrum is expanding in US

Integrum, the world leader in osseointegrated prosthetics for amputees was excited to announce its inaugural participation as an exhibitor at the 2019 Amputee Coalition’s National Conference in San Antonio, Texas held July 25th-27th, 2019. Integrum has been a gold sponsor to the American Amputee Coalition since January 2019. The American Amputee Coalition is a non-profit organization with more than 500 000 members dedicated to enhancing the quality of life for amputees and their families through support, education and advocacy. The Amputee Coalition’s National Conference provided

Increased number of shares and votes in Catena Media plc

The number of shares and votes in Catena Media plc amounts to 58,429,598 following a directed share issue of a total of 1,440,454 shares.Catena Media has, as announced on 16 July 2019 , resolved on a directed share issue of a total of 1,440,454 shares as a prepayment to the final earn-out payment for U.S. assets acquired in December 2016. The share issue has been registered with the Maltese authorities in July 2019.

Raute Corporation - Half-year report January 1 - June 30, 2019

RAUTE CORPORATION HALF-YEAR REPORT JULY 31, 2019 AT 9:00 a.m. This is a summary of Raute’s Half-year financial report January 1 – June 30, 2019. The complete report is attached to this release as a pdf file and is also available on the company’s’ website at www.raute.com.  RAUTE CORPORATION – HALF-YEAR REPORT JANUARY 1–JUNE 30, 2019  - The Group’s net sales, EUR 78.3 million (MEUR 78.9), decreased 0.8% from the comparison period. Order intake was EUR 58 million (MEUR 96).- Operating profit was EUR 4.9 million (MEUR 5.9), down 16% from the comparison period. The result before

Alligator Bioscience regains global rights from Janssen to CD40 agonistic antibody, ADC-1013 (JNJ-64457107)

Lund, Sweden, July 31, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that it has regained exclusive, worldwide rights from Janssen Biotech Inc. to develop and commercialize the CD40 agonistic antibody, ADC-1013 (JNJ-64457107), its lead tumor-directed immunotherapy candidate, in Phase I development for the treatment of metastatic cancer. The 2015 partnership agreement between Alligator and Janssen has been terminated as a result of a strategic portfolio decision by Janssen to prioritize other assets. Per Norlén, CEO of Alligator Bioscience, said: “Our ambition

Borr Drilling Limited Announces Pricing of Initial Public Offering in the United States

Hamilton, Bermuda — July 31, 2019 — Borr Drilling Limited (NYSE: BORR, OSE: BDRILL) (the "Company" or "Borr Drilling") today announced the pricing of its previously announced initial public offering in the United States of 5,000,000 of its common shares (the "Offering"), at a price to the public of $9.30 per common share (the "Offering Price"). Borr Drilling has also granted the underwriters of the Offering a 30-day option to purchase up to an additional 750,000 common shares at the Offering Price, less underwriting discounts and commissions. The Offering is expected to close on or about

Change of number of shares and votes in Green Landscaping Group AB (publ)

Pursuant to the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument), Swedish companies whose shares are listed on a regulated market and who increases or reduces the total number of shares or votes in the company is to disclose such changes on the last trading day the same month.As of 31 July 2019, there are in total 36 011 057 shares and votes in Green Landscaping Group AB (publ) (“Green” or the “Company”). The change in number of shares and votes in the Company is a result of the board of directors’ decision to issue in total 161 394

Targovax is invited to present at Solebury Trout European Biotech Investor Day in NYC

Oslo, Norway, 31 July 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that the Company is invited to present at the Solebury Trout European Biotech Investor Day 2019 in NYC. Date: 1 August 2019Time: 10:30 AM EDTPresenter: Øystein Soug (CEO) The presentation will be available to download at www.targovax.com after the event.

YIT Corporation: Managers’ transactions – Tercero Invest AB

YIT Corporation                  Managers' transactions      July 31, 2019 at 08:00 a.m.YIT Corporation: Managers’ transactions – Tercero Invest AB YIT Corporation has received the following notification: YIT Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Tercero Invest AB Position: Closely associated person (X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer Name: Ehrnrooth, Alexander Position: Member of the Board Issuer: YIT Oyj LEI:

Tobii Introduces Tobii Spotlight Technology™

At the SIGGRAPH 2019 conference in Los Angeles, Tobii announced Tobii Spotlight Technology, an eye tracking technology that delivers the powerful benefits of foveated rendering today and will enable an even broader set of foveation-related capabilities in the future. Foveation in visual systems refers to the capability to process just the information at the center of focus in high detail. Just as the human eye is optimized to focus in exceptional detail on a small fraction of an image, Tobii Spotlight Technology brings nature’s design for human vision to the devices we use, and will use,

FlexQube receives the first order for an eQart® from Germany!

FlexQube has received the first order for an eQart® from Daimler in Germany.The eQart® is the first product arising from the project “FlexQube 4.0” and it is an autonomous and remote-controlled cart that can be configured in almost any shape due to it is built with the FlexQube building blocks that has been complemented with digital modules such as motors, battery, control unit and sensors. Planned delivery is middle of September 2019, provided that the current certification process will be approved and done at the end of August 2019. The goal with the eQart® is to offer the most user-

YIT   Corporation: SHARE REPURCHASE 30.7.2019

YIT   Corporation ANNOUNCEMENT 30.7.2019 YIT   Corporation: SHARE REPURCHASE 30.7.2019 In the Helsinki Stock   Exchange Trade date          30.7.2019Bourse trade        BuyShare                  YITAmount            60 000 SharesAverage price/ share    4,9326 EURTotal cost            295 956,00 EUR YIT   Corporation now holds a total of 1030 504 sharesincluding   the shares repurchased on 30.7.2019 On behalf of YIT Corporation Nordea Bank Oyj

Mandatory notification of trade

On 30 July 2019, Flakk Composites AS sold 2,000,000 shares of Hexagon Composites ASA to companies wholly owned by Ms. Maria Lilly Flakk, daughter of Mr. Knut Flakk who is Chairman of the Board in Hexagon Composites ASA. Flakk Composites AS is wholly owned by Flakk Gruppen AS, a company owned 98.7% by Mr. Knut Flakk. The price per share in the transaction is NOK 36.00. The holding of Flakk Composites AS after the transaction is 27,340,504 shares (14.9%), and the total holding of Mr. Knut Flakk and his close associates after the transaction is 29,284,969 shares (16.0%). This information

There are no items matching the current filter
There are no more items matching the current filter
Back to top